Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Goldstein

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cephalalgia : an International Journal of Headache|October 11, 2013
Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: a randomized studyStephen Silberstein, Susan A McDonald, Jerome Goldstein, et al.
Headache|August 20, 2005
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trialJerome Goldstein, Stephen D Silberstein, Joel R Saper, et al.
Headache|May 20, 2011
Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response surveyRoger Cady, Jim Banks, Robert B Nett, et al.
Cephalalgia : an International Journal of Headache|August 1, 2014
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled studyDavid W Dodick, Stephen D Silberstein, Kenneth L Reed, et al.
Cephalalgia : an International Journal of Headache|October 5, 2012
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled studyStephen D Silberstein, David W Dodick, Joel Saper, et al.
The Lancet. Neurology|February 5, 2013
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trialRichard Dodel, Axel Rominger, Peter Bartenstein, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cephalalgia : an International Journal of Headache|October 11, 2013
Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: a randomized studyStephen Silberstein, Susan A McDonald, Jerome Goldstein, et al.
Headache|August 20, 2005
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trialJerome Goldstein, Stephen D Silberstein, Joel R Saper, et al.
Headache|May 20, 2011
Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response surveyRoger Cady, Jim Banks, Robert B Nett, et al.
Cephalalgia : an International Journal of Headache|August 1, 2014
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled studyDavid W Dodick, Stephen D Silberstein, Kenneth L Reed, et al.
Cephalalgia : an International Journal of Headache|October 5, 2012
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled studyStephen D Silberstein, David W Dodick, Joel Saper, et al.
The Lancet. Neurology|February 5, 2013
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trialRichard Dodel, Axel Rominger, Peter Bartenstein, et al.
Pageof 3